Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Compared with patients with stage I/II periodontitis, patients with stage III and IV periodontitis had higher blood pressure, total cholesterol, low-density lipoprotein, glycosylated hemoglobin, OGTT 2 h blood glucose, and white blood cell count, lower 25-hydroxyvitamin D levels, and higher proportions of hypertension, diabetes, hyperlipidemia, cardiovascular disease, osteoporosis, and arthritis.Characteristics of the study population overall and stratified by periodontal status Stage I/II Stage III Stage IV Total P Number 5368619812378 Age 51.04 ± 9.0855.32 ± 10.2061.62 ± 10.0156.95 ± 10.74 < 0.001 Gender 0.017 Male227 (42,35)430 (49.94)476 (48.52)1133 (47.65) Female309 (57.65)431 (50.06))505 (51.48)1245 (52.35) Race < 0.001 Mexican American55 (10.26)166 (19.28)120 (12.23)341 (14.34) Other Hispanic30 (5.6)87 (10.10)110 (11.21)227 (9.55) Non-Hispanic black307 (57.28)354 (41.11)383 (39.04)1044 (43.90) Non-Hispanic white49 (9.14)134 (15.56)257 (26.20)440 (18.50) Other95 (17.72)120 (13.94)111 (11.31)326 (13.71) Number of lost teeth 0.52 ± 1.272.21 ± 1.4415.13 ± 8.537.16 ± 8.73 < 0.001BMI (kg/m2)29.00 ± 6.6629.64 ± 6.6129.77 ± 6.9529.55 ± 6.760.096 Systolic blood pressure (mmHg) 119.68 ± 15.29125.47 ± 16.42130.17 ± 19.68126.07 ± 18.03 < 0.001 Diastolic blood pressure (mmHg) 71.85 ± 10.2272.51 ± 10.8570.51 ± 12.4071.55 ± 11.400.001 TC (mmol/L) 5.15 ± 1.035.12 ± 1.234.94 ± 1.065.05 ± 1.12 < 0.001 TG (mmol/L) 1.36 ± 1.191.52 ± 2.501.41 ± 0.981.44 ± 1.700.417 LDL (mmol/L) 3.08 ± 0.933.16 ± 0.852.92 ± 0.923.01 ± 0.900.025 HbA1c (%) 5.64 ± 0.915.93 ± 1.156.14 ± 1.345.95 ± 1.20 < 0.001 OGTT 2 h blood glucose (mmol/L) 6.72 ± 2.706.73 ± 2.447.33 ± 3.586.95 ± 2.990.017 25-hydroxyvitamin D (nmol/L) 76.12 ± 30.0668.19 ± 27.9567.06 ± 30.0669.51 ± 29.52 < 0.001White blood cell (*109/L)6.88 ± 2.077.19 ± 2.137.32 ± 2.197.17 ± 2.15 < 0.001 Hemoglobin (g/dL) 14.02 ± 1.3814.09 ± 1.4613.79 ± 1.5313.95 ± 1.48 < 0.001 Alcohol consumption (≥ 12drinks per year) 397(78.46)611(74.24)631(67.63)1639(72.46) < 0.001 Smoking (≥ 100 cigarettes in life) 162(30.22)344(39.95)592(60.41)1098(46.19) < 0.001 Hypertension 204(38.06)411(47.74)628(64.02)1243(52.27) < 0.001 Diabetes 67(12.50)181(21.02)293(29.87)541(22.75) < 0.001 Hyperlipidemia 286(53.36)478(55.52)596(60.75)1360(57.19)0.010 Cardiovascular disease 17(3.17)48(5.59)131(13.42)196(8.27) < 0.001 Osteoporosis 21(3.92)58(6.77)90(9.19)169(7.12) < 0.001 Arthritis 136(25.37)252(29.30)425(43.46)813(34.25) < 0.001 Cancer 56(10.45)74(8.59)131(13.35)261(10.98)0.005 Thyroid disease 68(12.69)100(11.66)126(12.87)294(12.39)0.712 α-Klotho (pg/mL) 896.16 ± 304.84871.08 ± 266.42840.52 ± 286.24864.13 ± 284.35 < 0.001Continuous variables are shown as X̅ ± SD, categorical variables are shown as N(%); The Absent values includes: Alcohol consumption (n = 116, 4.88%), Smoking (n = 1, < 0.01%), Cardiovascular disease (n = 7, < 0.01%), Osteoporosis (n = 4, < 0.01%), Arthritis (n = 4, < 0.01%), Thyroid disease (n = 5, < 0.01%)

Source: General characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Cross-sectional study data of participants aged between 40 and 79 years in the National Health and Nutrition Examination Survey 2013 to 2014 were selected and analyzed.

Source: Abstract.

The cross-sectional study was based on data from the National Health and Nutrition Examination Survey (NHANES), which was conducted by the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS) in 2-year cycles and examined the health and nutrition condition of a representative U.S.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Correlation between serum α-Klotho levels and different stages of periodontitis

Cross-sectional study · BMC Oral Health · 2023

Original publication title

Correlation between serum α-Klotho levels and different stages of periodontitis

Can Ni; Dongyu Bao; Fuhua Yan; Bin Chen

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The serum α-Klotho levels were negatively correlated with the severity of periodontitis. With the aggravation of periodontitis stages, the serum α-Klotho levels gradually decreased.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Periodontitis is an inflammatory disease characterized by inflammation and progressive destruction of periodontal tissues including alveolar bone. α-klotho protein is a multifunctional protein related to age-related diseases, inflammatory diseases, and bone metabolism-related diseases. However, large-sample epidemiological research evidence on the correlation between α-Klotho and the aggravation of periodontitis stages is still lacking.

Source: Background

Abstract: What methods does the paper describe?

Cross-sectional study data of participants aged between 40 and 79 years in the National Health and Nutrition Examination Survey 2013 to 2014 were selected and analyzed. The stages of periodontitis of the participants were determined according to the 2018 World Workshop Classification of Periodontal and Peri-implant Diseases. The serum α-Klotho levels in people with periodontitis in different stages were evaluated. Then the correlation between serum α-Klotho levels and different stages of periodontitis was analyzed by multiple linear regression (stepwise regression method).

Source: Methods

Abstract: Results

A total of 2378 participants were included in the study. The serum α-Klotho levels in people with stage I/II, III and IV periodontitis were 896.16 ± 304.84, 871.08 ± 266.42 and 840.52 ± 286.24 pg/mL, respectively. The levels of α-Klotho in people with stage IV periodontitis were significantly lower than those in people with stage I/II and III periodontitis. Linear regression analysis results showed that compared to stage I/II periodontitis, serum α-Klotho levels were significantly negatively correlated with stage III (B ± SE = -37.28 ± 16.00, 95% CI: -68.66 ~ -25.91, P = 0.020) and stage IV (B ± SE = -69.37 ± 16.11, 95% CI: -100.97 ~ -37.77, P < 0.001) periodontitis.

Source: Results

Abstract: Conclusion

The serum α-Klotho levels were negatively correlated with the severity of periodontitis. With the aggravation of periodontitis stages, the serum α-Klotho levels gradually decreased.

Source: Conclusion
Authors’ abstract

Background

Periodontitis is an inflammatory disease characterized by inflammation and progressive destruction of periodontal tissues including alveolar bone. α-klotho protein is a multifunctional protein related to age-related diseases, inflammatory diseases, and bone metabolism-related diseases. However, large-sample epidemiological research evidence on the correlation between α-Klotho and the aggravation of periodontitis stages is still lacking.

Methods

Cross-sectional study data of participants aged between 40 and 79 years in the National Health and Nutrition Examination Survey 2013 to 2014 were selected and analyzed. The stages of periodontitis of the participants were determined according to the 2018 World Workshop Classification of Periodontal and Peri-implant Diseases. The serum α-Klotho levels in people with periodontitis in different stages were evaluated. Then the correlation between serum α-Klotho levels and different stages of periodontitis was analyzed by multiple linear regression (stepwise regression method).

Results

A total of 2378 participants were included in the study. The serum α-Klotho levels in people with stage I/II, III and IV periodontitis were 896.16 ± 304.84, 871.08 ± 266.42 and 840.52 ± 286.24 pg/mL, respectively. The levels of α-Klotho in people with stage IV periodontitis were significantly lower than those in people with stage I/II and III periodontitis. Linear regression analysis results showed that compared to stage I/II periodontitis, serum α-Klotho levels were significantly negatively correlated with stage III (B ± SE = -37.28 ± 16.00, 95% CI: -68.66 ~ -25.91, P = 0.020) and stage IV (B ± SE = -69.37 ± 16.11, 95% CI: -100.97 ~ -37.77, P < 0.001) periodontitis.

Conclusion

The serum α-Klotho levels were negatively correlated with the severity of periodontitis. With the aggravation of periodontitis stages, the serum α-Klotho levels gradually decreased.

Publication and source details

Original title: Correlation between serum α-Klotho levels and different stages of periodontitis

Can Ni; Dongyu Bao; Fuhua Yan; Bin Chen

BMC Oral Health · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100001809National Natural Science Foundation of China82001051Ni Can http://dx.doi.org/10.13039/501100004608Natural Science Foundation of Jiangsu ProvinceBK20220199Chen Bin

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T18:37:08.564254+00:00

DOI: 10.1186/s12903-023-03099-4 · PMC10249151